University of Melbourne

The University of Melbourne, established in 1853, is a prominent public institution in Australia recognized for its contributions to research, learning, and community engagement. It consistently ranks among the top universities globally, being the highest-ranked in Australia and 33rd worldwide according to the Times Higher Education World University Rankings for 2014-2015. The university operates a non-profit endowment fund that manages philanthropic contributions from donors, supporting its educational and research missions. Additionally, the University of Melbourne Endowment Fund functions as an early-stage venture capital fund, focusing on investments in sectors such as information technology services, pharmaceuticals, biotechnology, technology, media and telecommunications, and e-commerce.

Geoffrey Donnan

Director FNI

15 past transactions

Synchron

Series C in 2022
Synchron is a medical technology company focused on developing innovative brain-computer interface solutions. It manufactures an implantable device known as the stentrode, which is delivered to the brain via a catheter. This minimally invasive device is embedded with electrode arrays that can interpret neuronal signals and modulate neural activity in targeted areas. By enabling patients with motor impairments to control digital devices, prosthetics, and other assistive technologies through thought, Synchron aims to enhance the quality of life for individuals with disabilities.

Tiny Bright Things

Seed Round in 2022
Tiny Bright Things is a Melbourne-based company founded in 2020 by Ray Dagastine and Chris Bolton. The company specializes in developing Halo microscopy technology that significantly enhances the imaging and measurement of small or transparent objects. This innovative technology serves both industrial manufacturers and researchers, particularly in fields such as agrichemicals, pharmaceuticals, nanotechnology, and life sciences. By enabling precise imaging and measurement down to the scale of viruses, drug particles, and nanotubes without altering the samples, Tiny Bright Things provides essential tools for accurate analysis at any length scale, thereby supporting advancements in scientific discovery and manufacturing processes.

AIBUILD

Seed Round in 2021
Proudly partnered with The University of Melbourne and the Australian Research Council, AIBUILD is a big data and innovative solutions provider founded in 2017 as an emerging Australian startup. AIBUILD positions itself as a professional industry innovative solutions provider. Over the last three years in Australia, we have developed big data and software solutions for clients in industries ranging from the real estate industry to education and research, including: JH Market - Multi-warehouse solutions + distributed system for large industrial electrical products supplier (JinHang Lighting & Electrical) MyMart – Innovative e-commerce + smart supply chain solution for large Asian groceries (KT Mart) HousePro – Innovative real-time VR+AI matching system in global real-estate industry Crowdfunding platform - ARC IH150100006 (The University of Melbourne, Monash University, Australian Research Council) Otaro - Real-time online panorama/VR teaching platform (The University of Melbourne) A smart wind-driven natural ventilation system for buildings (The University of Melbourne, RMIT) We aim to ensure the widespread use of Artificial Intelligence Technology in Australia by helping our enterprise clients reduce costs and Improve consistency in their processes with Artificial Intelligence (AI) and virtual reality (VR) technology. We remain firmly committed to providing unparalleled quality design and impeccable service to ensure we meet the ranging needs of all our customers.

Synchron

Series B in 2021
Synchron is a medical technology company focused on developing innovative brain-computer interface solutions. It manufactures an implantable device known as the stentrode, which is delivered to the brain via a catheter. This minimally invasive device is embedded with electrode arrays that can interpret neuronal signals and modulate neural activity in targeted areas. By enabling patients with motor impairments to control digital devices, prosthetics, and other assistive technologies through thought, Synchron aims to enhance the quality of life for individuals with disabilities.

AIBUILD

Pre Seed Round in 2020
Proudly partnered with The University of Melbourne and the Australian Research Council, AIBUILD is a big data and innovative solutions provider founded in 2017 as an emerging Australian startup. AIBUILD positions itself as a professional industry innovative solutions provider. Over the last three years in Australia, we have developed big data and software solutions for clients in industries ranging from the real estate industry to education and research, including: JH Market - Multi-warehouse solutions + distributed system for large industrial electrical products supplier (JinHang Lighting & Electrical) MyMart – Innovative e-commerce + smart supply chain solution for large Asian groceries (KT Mart) HousePro – Innovative real-time VR+AI matching system in global real-estate industry Crowdfunding platform - ARC IH150100006 (The University of Melbourne, Monash University, Australian Research Council) Otaro - Real-time online panorama/VR teaching platform (The University of Melbourne) A smart wind-driven natural ventilation system for buildings (The University of Melbourne, RMIT) We aim to ensure the widespread use of Artificial Intelligence Technology in Australia by helping our enterprise clients reduce costs and Improve consistency in their processes with Artificial Intelligence (AI) and virtual reality (VR) technology. We remain firmly committed to providing unparalleled quality design and impeccable service to ensure we meet the ranging needs of all our customers.

Apromore

Series A in 2020
Apromore is a provider of process mining solutions aimed at enhancing organizational efficiency and effectiveness. The platform enables business teams to visualize, analyze, and improve existing processes by utilizing data from various enterprise systems. Apromore's technology is built on an open-source foundation and incorporates AI-driven capabilities, facilitating a user-friendly experience with a wide range of data connections. This allows organizations to identify inefficiencies, friction points, and compliance violations within their processes. By leveraging advanced data science techniques in a no-code environment, Apromore empowers teams to make informed decisions and achieve operational excellence, ultimately leading to improved customer experiences and better risk management.

Denteric

Series A in 2019
Denteric is a biotechnology company focused on developing a vaccine to combat periodontal diseases. Based on research from the University of Melbourne and supported by CSL Limited, Denteric's innovative platform targets virulence factors produced by the bacterium Porphyromonas gingivalis, which is associated with various dental diseases. The company's goal is to provide effective treatments that address both the disease itself and its complications, ultimately improving patient health outcomes in the field of dentistry.

Tiny Bright Things

Pre Seed Round in 2019
Tiny Bright Things is a Melbourne-based company founded in 2020 by Ray Dagastine and Chris Bolton. The company specializes in developing Halo microscopy technology that significantly enhances the imaging and measurement of small or transparent objects. This innovative technology serves both industrial manufacturers and researchers, particularly in fields such as agrichemicals, pharmaceuticals, nanotechnology, and life sciences. By enabling precise imaging and measurement down to the scale of viruses, drug particles, and nanotubes without altering the samples, Tiny Bright Things provides essential tools for accurate analysis at any length scale, thereby supporting advancements in scientific discovery and manufacturing processes.

Certa Therapeutics

Grant in 2018
Certa Therapeutics, established in 2017 and headquartered in Melbourne, Australia, is a biotechnology company specializing in the development of precision medicines for fibrotic diseases, with a primary focus on kidney disorders. The company employs genetic analysis to identify patients at risk of developing kidney fibrosis, a precursor to end-stage kidney failure. Certa's drug pipeline targets a key receptor driving kidney fibrosis, aiming to halt or reverse the scarring process and prevent the need for dialysis or transplantation. Currently in the clinical stage, the company's mission is to transform the treatment landscape for fibrotic diseases by enabling early intervention and improving patient outcomes.

Clarity Pharmaceuticals

Venture Round in 2016
Clarity Pharmaceuticals is a clinical-stage radiopharmaceutical company specializing in the development of innovative theranostic products that combine therapy and imaging. Utilizing its proprietary SAR Technology, Clarity focuses on creating next-generation radiopharmaceuticals that leverage copper isotopes for enhanced imaging and therapeutic effectiveness. The company's platform technology facilitates the radiolabeling of antibodies, which can be visualized through PET imaging. This process generates crucial human imaging data that informs whether a drug effectively targets the disease in a patient, thereby enabling a personalized approach to treatment. By identifying patients likely to benefit from specific therapies, Clarity is advancing precision medicine in the field of oncology and addressing existing challenges in the radiopharmaceutical sector.

Hatchtech

Venture Round in 2013
Hatchtech is an Australian company focused on developing a proprietary technology platform aimed at creating low-toxicity pest control products. The company's patented technology offers a novel mode of action that effectively blocks the hatching of pest species' eggs, making it applicable for managing ectoparasites and other egg-laying pests affecting humans, animals, crops, and built environments. Hatchtech also provides a specialized pharmaceutical product that delivers a single-dose, topical treatment designed to eliminate head lice infestations by killing both the lice and their eggs in one application. Through its innovative approaches, Hatchtech seeks to advance pest control solutions with reduced environmental impact.

Omny Studio

Grant in 2012
Omny Studio is a comprehensive audio management and publishing platform tailored for content creators, including radio stations and podcasters. The company's software-as-a-service solution streamlines the distribution, analysis, monetization, and archiving of on-demand audio content. By facilitating seamless transitions across various aspects of the workflow, Omny Studio integrates with live streaming services, content management systems, and advertising platforms. This allows users to focus on producing high-quality content while effectively growing their audience and reducing production costs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.